Buy This Pharma Stock For A Target Price Of Rs 870 Offering 735% Dividend; Turning Ex-Dividend Soon

Leading brokerage Anand Rathi has given buy call to the stock of Eris Lifesciences Ltd for a target price of Rs 870 apiece with a potential gain of 26%. Driven by its standalone business (up 11%) and Oaknet acquisition (Rs315m), Eris'

from Tax Saving Investments | Tax Saving Tips & News | Income Tax India – Oneindia Money https://ift.tt/S94VNE6
via IFTTT